Related Experiment Video
Updated: Sep 13, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Antiarrhythmic effects of diazepam during coronary artery occlusion in dogs
Abstract:
The ventral interventricular branch of the left coronary artery was ligated in a 2-step operation in 10 dogs whose electrocardiograms and systemic arterial blood pressures were then monitored during the next 7 days. Monitoring was done in awake dogs given 1 mg of diazepam per kilogram of body weight (intravenously administered in 3 dogs and orally in 7). Because ventricualr ectopic activity was greatest during the interval of 10 to 48 hours after ligation, the antiarrhythmic activity of diazepam was recorded during this 38-hour interval. After administration of diazepam by either route, frequency of ventricular ectopic beats decreased from 98 to 80%. THIS REDUCTION BETAN IMMEDIATELY AFTER THE INTRAVENOUS ADMINISTRATION AND PERSISTED FOR ONLY 5 MINUTES; REDUCTION BEGAN APPROXIMATELY 1 HOUR AFTER THE ORAL ADMINISTRATION AND PERSISTED 4 TO 6 HOURS. Systemic arterial blood pressure decreased only after the intravenous administration. It is concluded that diazepam is effective in reducing the frequency of ventricular ectopic activity after occlusion of major branches of coronary arteries, that diazepam works independent of alterations in systemic arterial blood pressure, and that orally administered diazepam prolongs antiarrhythmic activity. Possibly, the adjuvants present in the parenteral form of diazepam reduce antiarrhythmic activity by being, themselves, arrhythmogenic.
More Related Videos
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inotropic Agents
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...